Rare lephants
Screener

PMGC Holdings Inc.

ELAB ·Healthcare, Drug Manufacturers - General, United States
Analysis › Moat Score

Moat Score — PMGC Holdings Inc.

Total Moat Score 6 / 30
Moat Factor Score Analysis
Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. 2 / 5 PMGC holds a growing patent estate for EL-22 across Korea, the US, Japan, and China plus pending EL-32 applications, and its AGA Precision subsidiary carries ITAR/AS9100 certifications, but the overall IP base is thin relative to its much larger biotech and industrial competitors.
Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. 1 / 5 As a newly assembled, small-scale conglomerate with only 32 full-time employees, PMGC has no demonstrated cost advantage; operating cash consumption significantly exceeds its $590,084 of 2025 revenue.
Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. 1 / 5 With EL-22 still pre-commercial and its packaging/machining subsidiaries competing against larger players on price, PMGC currently has little to no pricing power.
Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. 0 / 5 None of PMGC's four subsidiaries (biotech, capital, packaging, machining) exhibit network-effect dynamics.
Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. 1 / 5 Pacific Sun Packaging's 300+ commercial customers and AGA Precision's aerospace/defense qualification processes create mild switching costs, but these are not yet a strong moat.
Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. 1 / 5 PMGC's niche aerospace-machining and IT-packaging operations are far too small to constitute an efficient-scale barrier, and its biotech asset has no commercial scale at all yet.